BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2722975)

  • 21. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
    Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
    Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified model for adjustment of gentamicin dosage in newborn infants.
    Herngren L; Broberger U; Wretlind B
    Acta Paediatr Scand; 1986 Mar; 75(2):198-204. PubMed ID: 3962654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline.
    Kanthawatana S; Uruwannakul K; Chotinarumon S
    J Med Assoc Thai; 1998 Feb; 81(2):136-40. PubMed ID: 9529844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gentamicin disposition in young and elderly patients with various degrees of renal function.
    Matzke GR; Jameson JJ; Halstenson CE
    J Clin Pharmacol; 1987 Mar; 27(3):216-20. PubMed ID: 3680577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of radioimmunoassay and enzyme immunoassay methods in determining gentamicin pharmacokinetic parameters and dosages.
    Rotschafer JC; Morlock C; Strand L; Crossley K
    Antimicrob Agents Chemother; 1982 Oct; 22(4):648-51. PubMed ID: 6758688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gentamicin volume of distribution in critically ill septic patients.
    Triginer C; Izquierdo I; Fernández R; Rello J; Torrent J; Benito S; Net A
    Intensive Care Med; 1990; 16(5):303-6. PubMed ID: 2212254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the use of Bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing.
    Chrystyn H
    Drug Intell Clin Pharm; 1988 Jan; 22(1):49-53. PubMed ID: 3349920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial dosage regimens of gentamicin in patients with burns.
    Zaske DE; Chin T; Kohls PR; Solem LD; Strate RG
    J Burn Care Rehabil; 1991; 12(1):46-50. PubMed ID: 2022681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery.
    Tudor RA; Papich MG; Redding WR
    J Am Vet Med Assoc; 1999 Aug; 215(4):503-6. PubMed ID: 10461634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
    Lackey MN; Belknap EB; Greco DS; Fettman MJ
    Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
    Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
    Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of gentamicin in horses.
    Martín-Jiménez T; Papich MG; Riviere JE
    Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of a physiological model of gentamicin pharmacokinetics for individual dosage of the antibiotic].
    Manuĭlov KK; Kuleshov SE; Obolonkov VIu; Liubovina AB
    Antibiot Khimioter; 1992 Aug; 37(8):35-7. PubMed ID: 1456824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.